Characteristics of NAFLD Among Type 2 Diabetes Patients | MicrobiomeTrials← Back to trialsNCT04999124
Characteristics of NAFLD Among Type 2 Diabetes Patients
CompletedNAINTERVENTIONAL
Trial Details
Start: 2020-01-01Est. Completion: 2026-06-30
Enrollment target: 1,762 participants Locations- Ziekenhuis Oost-Limburg, Genk, Belgium
Other microbiome trials you might be interested in
Obesity, MorbidMetabolic SyndromeNASH - Nonalcoholic Steatohepatitis
Variable outcomes after weight loss surgery are likely attributable to complex, poorly understood mechanisms. Due to the…
Columbia, United StatesCompleted Mar 1, 2031
Non-alcoholic Fatty Liver Disease (NAFLD)Dyslipidaemia
Non-alcoholic fatty liver disease is a chronic, serious, life-threatening, inflammatory liver disease characterized by i…
Melbourne, AustraliaEst. completion Dec 2026
Bariatric Sleeve Gastrectomy
Asprosin and neuregulin 4 (NRG4) sit on opposing arms of adipose endocrine physiology. Asprosin is a fasting-induced, wh…
Alexandria, EgyptCompleted Jul 17, 2026